These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 94863)

  • 1. On the pharmacology of venous smooth muscle from dog and man.
    Müller-Schweinitzer E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):690-704. PubMed ID: 94863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental pharmacological studies of the venous tonus-modifying effect of dihydroergotamine].
    Glusa E
    Z Gesamte Inn Med; 1984 Sep; 39(17):414-7. PubMed ID: 6095548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of ergot alkaloids on venous tonus determined in superficial hand veins in situ].
    Aellig WH
    Cardiology; 1976; 61 suppl 1():302-8. PubMed ID: 975144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
    Villalón CM; De Vries P; Rabelo G; Centurión D; Sánchez-López A; Saxena P
    Br J Pharmacol; 1999 Feb; 126(3):585-94. PubMed ID: 10188968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prejunctional adrenergic receptors and sympathetic neurotransmission: studies in canine skeletal muscle vasculature in situ.
    Kahan T
    Acta Physiol Scand Suppl; 1987; 560():1-38. PubMed ID: 2884804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct effects of vasoactive substances on superficial human veins in vivo.
    Aellig WH
    Int Angiol; 1985; 4(2):235-42. PubMed ID: 3913713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of bucindolol in isolated canine vascular smooth muscle.
    Rimele TJ; Aarhus LL; Lorenz RR; Rooke TW; Vanhoutte PM
    J Pharmacol Exp Ther; 1984 Nov; 231(2):317-25. PubMed ID: 6149305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 2-adrenergic agonist and alpha 1-adrenergic antagonist activity of ergotamine and dihydroergotamine in rats.
    Roquebert J; Grenié B
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):30-7. PubMed ID: 2881518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological basis of the treatment of orthostatic disorders with ergot alkaloids.
    Stürmer E
    Cardiology; 1976; 61 suppl 1():290-301. PubMed ID: 975143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for studying drug effects on superficial human veins.
    Aellig WH
    Methods Find Exp Clin Pharmacol; 1985 Jun; 7(6):321-4. PubMed ID: 3840550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic pharmacology of human and canine peripheral veins.
    Vanhoutte PM; Shepherd JT
    Fed Proc; 1985 Feb; 44(2):337-40. PubMed ID: 2857141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular responses of isolated canine and simian femoral arteries and veins to alpha-adrenoceptor agonists.
    Kawai K; Chiba S
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):201-11. PubMed ID: 2881521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroergotamine: pharmacokinetics, pharmacodynamics, and mechanism of venoconstrictor action in beagle dogs.
    Müller-Schweinitzer E; Rosenthaler J
    J Cardiovasc Pharmacol; 1987 Jun; 9(6):686-93. PubMed ID: 2442535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro studies on the duration of action of dihydroergotamine.
    Müller-Schweinitzer E
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):88-91. PubMed ID: 7372380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on 5-hydroxytryptamine receptors on isolated human femoral veins and arteries and the influence of dihydroergotamine.
    Glusa E; Markwardt F
    Pharmacology; 1984; 29(6):336-42. PubMed ID: 6505006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins.
    Müller-Schweinitzer E
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):299-303. PubMed ID: 6096723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual effect of dihydroergotamine and dihydroergotoxin in isolated human femoral veins and arteries.
    Glusa E; Markwardt F
    Pharmacology; 1982; 24(5):287-93. PubMed ID: 6285391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The action of adrenoceptor agonists and antagonists on the guinea pig and dog trachea.
    Bilcíková L; Bauer V; Kolena J
    Gen Physiol Biophys; 1987 Feb; 6(1):87-101. PubMed ID: 2885244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular effects of ergot alkaloids: a study on human basilar arteries.
    Müller-Schweinitzer E
    Gen Pharmacol; 1983; 14(1):95-102. PubMed ID: 6826043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An attempt to characterize alpha-adrenoceptors on human dorsal foot veins in situ.
    Barthel W
    Int J Clin Pharmacol Ther Toxicol; 1993 Jun; 31(6):267-70. PubMed ID: 8101513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.